期刊文献+

膜联蛋白A7过表达对人胃癌MGC-803细胞增殖和凋亡的影响

Effects of ANXA7 Overexpression on Proliferation and Apoptosis of Human Gastric Cancer MGC-803 Cells
下载PDF
导出
摘要 目的探讨膜联蛋白A7(ANXA7)过表达对人胃癌MGC-803细胞增殖和凋亡的影响。方法将人胃癌MGC-803细胞分为ANXA7过表达组、阴性对照组,脂质体转染法将pcDNA3.1-ANXA7重组质粒以及空质粒分别转染ANXA7过表达组和阴性对照组。采用Western blot鉴定ANXA7过表达;转染48h采用CCK-8实验检测各组细胞增殖能力;流式细胞术检测各组细胞凋亡率;Western blot检测各组细胞增殖和凋亡相关蛋白PCNA、CyclinD1、Casepase-3、Cleaved casepase-3的表达。结果与阴性对照组相比,ANXA7过表达组MGC-803细胞增殖能力显著增强、PCNA与CyclinD1的表达均升高(P<0.05);细胞凋亡率降低、Cleaved casepase-3的表达降低(P<0.05);Casepase-3的表达变化无统计学意义(P>0.05)。结论ANXA7过表达可促进人胃癌MGC-803细胞的增殖并抑制其凋亡。 Objective To investigate the effects of annexinA7(ANXA7)overexpression on the proliferation and apoptosis of human gastric cancer MGC-803 cells.Methods Human gastric cancer MGC-803 cells were divided into ANXA7 overexpression group and negative control group.PcDNA3.1-ANXA7 recombinant plasmid and empty plasmid were transfected into ANXA7 overexpression group and negative control group respectively by liposome transfection.The overexpression of ANXA7 was detected by Western blot.CCK-8 assay was used to detect the proliferation ability of cells in each group.Cell apoptosis rate was detected by flow cytometry,and the expressions of PCNA,CyclinD1,Casepase-3 and Cleaved Casepase-3 were detected by Western blot.Results Compared with the negative control group,the proliferation ability of MGC-803 cells in the ANXA7 overexpression group was significantly enhanced,and the expression of PCNA and CyclinD1 were both increased(P<0.05).Apoptosis rate and Cleaved casepase-3 expression were decreased(P<0.05).The expression of Casepase-3 was not statistically significant(P>0.05).Conclusion The overexpression of ANXA7 can promote the proliferation and inhibit the apoptosis of human gastric cancer MGC-803 cells.
作者 王小杰 柏友兰 刘明伟 王新杰 李宏伟 李欣 WANG Xiao-jie;BAI You-lan;LIU Ming-wei;WANG Xin-jie;LI Hong-wei;LI Xin(School of Basic Medicine,Chengde Medical University,Chengde,Hebei,067000,China;Chengde Central Hospital;Chengde Weichang Manchu and Mongolian Autonomous County Hospital)
出处 《承德医学院学报》 2021年第4期288-291,共4页 Journal of Chengde Medical University
基金 河北省教育厅项目(Z2014026,ZD2018058) 河北省科技厅项目(10276142)。
关键词 ANXA7 MGC-803细胞 增殖 凋亡 ANXA7 MGC-803 cells proliferation apoptosis
  • 相关文献

参考文献3

二级参考文献31

  • 1Hung KS,Howng SL.Prognostic significance of annexin VII expression in glioblastomas multiforme in humans[J].中国神经肿瘤杂志,2003,1(4):199-199. 被引量:14
  • 2Wagner AD,Grothe W,Haerting J,et al.Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. Journal of Clinical Oncology . 2006
  • 3Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray.SJWD14121600000297[J]. Int. J. Cancer . 2015 (5)
  • 4Lin Shen,Jin Li,Jianming Xu,Hongming Pan,Guanghai Dai,Shukui Qin,Liwei Wang,Jinwan Wang,Zhenzhou Yang,Yongqian Shu,Ruihua Xu,Lei Chen,Yunpeng Liu,Shiying Yu,Lilian Bu,Yongzhe Piao.Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)[J]. Gastric Cancer . 2015 (1)
  • 5Hansjochen Wilke,Kei Muro,Eric Van Cutsem,Sang-Cheul Oh,Gy?rgy Bodoky,Yasuhiro Shimada,Shuichi Hironaka,Naotoshi Sugimoto,Oleg Lipatov,Tae-You Kim,David Cunningham,Philippe Rougier,Yoshito Komatsu,Jaffer Ajani,Michael Emig,Roberto Carlesi,David Ferry,Kumari Chandrawansa,Jonathan D Schwartz,Atsushi Ohtsu.Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial[J]. Lancet Oncology . 2014 (11)
  • 6Charles S Fuchs,Jiri Tomasek,Cho Jae Yong,Filip Dumitru,Rodolfo Passalacqua,Chanchal Goswami,Howard Safran,Lucas Vieira dos Santos,Giuseppe Aprile,David R Ferry,Bohuslav Melichar,Mustapha Tehfe,Eldar Topuzov,John Raymond Zalcberg,Ian Chau,William Campbell,Choondal Sivanandan,Joanna Pikiel,Minori Koshiji,Yanzhi Hsu,Astra M Liepa,Ling Gao,Jonathan D Schwartz,Josep Tabernero.Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial[J]. The Lancet . 2014 (9911)
  • 7Ruixuan Geng,Jin Li.Apatinib for the treatment of gastric cancer[J]. Expert Opinion on Pharmacotherapy . 2015 (1)
  • 8Elizabeth Won,Yelena J. Janjigian,David H. Ilson.HER2 Directed Therapy for Gastric/Esophageal Cancers[J]. Current Treatment Options in Oncology . 2014 (3)
  • 9Susan J Dutton,David R Ferry,Jane M Blazeby,Haider Abbas,Asa Dahle-Smith,Wasat Mansoor,Joyce Thompson,Mark Harrison,Anirban Chatterjee,Stephen Falk,Angel Garcia-Alonso,David W Fyfe,Richard A Hubner,Tina Gamble,Lynnda Peachey,Mina Davoudianfar,Sarah R Pearson,Patrick Julier,Janusz Jankowski,Rachel Kerr,Russell D Petty.Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial[J]. Lancet Oncology . 2014 (8)
  • 10G. Schinzari,A. Cassano,A. Orlandi,M. Basso,C. Barone.Targeted Therapy in Advanced Gastric Carcinoma: The Future is Beginning[J]. Current Medicinal Chemistry . 2014 (8)

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部